IOL CHEMICALS & PHARM. | SOLARA ACTIVE PHARMA SCIENCES | IOL CHEMICALS & PHARM./ SOLARA ACTIVE PHARMA SCIENCES |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.2 | -6.5 | - | View Chart |
P/BV | x | 1.5 | 1.3 | 113.1% | View Chart |
Dividend Yield | % | 1.0 | 0.0 | - |
IOL CHEMICALS & PHARM. SOLARA ACTIVE PHARMA SCIENCES |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
SOLARA ACTIVE PHARMA SCIENCES Mar-23 |
IOL CHEMICALS & PHARM./ SOLARA ACTIVE PHARMA SCIENCES |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 838 | 64.0% | |
Low | Rs | 272 | 324 | 84.1% | |
Sales per share (Unadj.) | Rs | 377.6 | 401.8 | 94.0% | |
Earnings per share (Unadj.) | Rs | 23.7 | -6.2 | -382.7% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 24.8 | 127.5% | |
Dividends per share (Unadj.) | Rs | 4.00 | 0 | - | |
Avg Dividend yield | % | 1.0 | 0 | - | |
Book value per share (Unadj.) | Rs | 256.8 | 417.2 | 61.5% | |
Shares outstanding (eoy) | m | 58.71 | 35.93 | 163.4% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 1.4 | 74.1% | |
Avg P/E ratio | x | 17.1 | -93.8 | -18.2% | |
P/CF ratio (eoy) | x | 12.8 | 23.5 | 54.6% | |
Price / Book Value ratio | x | 1.6 | 1.4 | 113.1% | |
Dividend payout | % | 16.9 | 0 | - | |
Avg Mkt Cap | Rs m | 23,743 | 20,875 | 113.7% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 2,286 | 73.6% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 14,438 | 153.6% | |
Other income | Rs m | 256 | 226 | 113.6% | |
Total revenues | Rs m | 22,427 | 14,664 | 152.9% | |
Gross profit | Rs m | 2,257 | 1,339 | 168.6% | |
Depreciation | Rs m | 462 | 1,112 | 41.5% | |
Interest | Rs m | 165 | 901 | 18.3% | |
Profit before tax | Rs m | 1,887 | -448 | -420.9% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | -226 | -219.4% | |
Profit after tax | Rs m | 1,391 | -223 | -625.3% | |
Gross profit margin | % | 10.2 | 9.3 | 109.8% | |
Effective tax rate | % | 26.2 | 50.4 | 52.1% | |
Net profit margin | % | 6.3 | -1.5 | -407.2% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 11,875 | 81.4% | |
Current liabilities | Rs m | 5,025 | 11,011 | 45.6% | |
Net working cap to sales | % | 20.9 | 6.0 | 349.8% | |
Current ratio | x | 1.9 | 1.1 | 178.4% | |
Inventory Days | Days | 43 | 8 | 556.7% | |
Debtors Days | Days | 8 | 14 | 61.3% | |
Net fixed assets | Rs m | 11,017 | 16,332 | 67.5% | |
Share capital | Rs m | 587 | 360 | 163.1% | |
"Free" reserves | Rs m | 14,490 | 14,632 | 99.0% | |
Net worth | Rs m | 15,077 | 14,992 | 100.6% | |
Long term debt | Rs m | 0 | 2,351 | 0.0% | |
Total assets | Rs m | 20,684 | 28,207 | 73.3% | |
Interest coverage | x | 12.5 | 0.5 | 2,479.3% | |
Debt to equity ratio | x | 0 | 0.2 | 0.0% | |
Sales to assets ratio | x | 1.1 | 0.5 | 209.4% | |
Return on assets | % | 7.5 | 2.4 | 312.9% | |
Return on equity | % | 9.2 | -1.5 | -621.8% | |
Return on capital | % | 13.6 | 2.6 | 521.5% | |
Exports to sales | % | 26.7 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | 5,930 | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 5,930 | 11,642 | 50.9% | |
Fx outflow | Rs m | 6,052 | 7,133 | 84.8% | |
Net fx | Rs m | -122 | 4,509 | -2.7% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 1,563 | 78.3% | |
From Investments | Rs m | -1,200 | -811 | 147.9% | |
From Financial Activity | Rs m | -41 | -1,128 | 3.6% | |
Net Cashflow | Rs m | -18 | -377 | 4.9% |
Indian Promoters | % | 48.2 | 30.5 | 158.1% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 18.8 | 9.1% | |
FIIs | % | 1.4 | 15.8 | 8.9% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 69.5 | 74.5% | |
Shareholders | 130,003 | 73,912 | 175.9% | ||
Pledged promoter(s) holding | % | 0.0 | 48.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | SOLARA ACTIVE PHARMA SCIENCES | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -1.18% | 16.32% | -0.44% |
1-Month | -4.51% | 49.28% | 2.15% |
1-Year | -4.09% | 47.64% | 49.82% |
3-Year CAGR | -12.01% | -27.74% | 14.21% |
5-Year CAGR | 15.35% | 6.52% | 19.19% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the SOLARA ACTIVE PHARMA SCIENCES share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of SOLARA ACTIVE PHARMA SCIENCES the stake stands at 30.5%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of SOLARA ACTIVE PHARMA SCIENCES.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
SOLARA ACTIVE PHARMA SCIENCES paid Rs 0.0, and its dividend payout ratio stood at -0.0%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of SOLARA ACTIVE PHARMA SCIENCES.
For a sector overview, read our pharmaceuticals sector report.
After opening the day deep in red, Indian share markets reversed the trend as the session progressed and ended on firm footing.